blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP Citations: EP4472679

Cited inInternational search
Type:Patent literature
Publication No.:WO2020243346  [X]
 (MASSACHUSETTS GEN HOSPITAL et al.)
Type:Patent literature
Publication No.:WO2017083198  [XY]
 (LILLY CO ELI et al.)
Type:Patent literature
Publication No.:WO2018005282  [Y]
 (LILLY CO ELI et al.)
Type:Patent literature
Publication No.:US2021284720  [Y]
 (KERCHNER GEOFFREY et al.)
Type:Patent literature
Publication No.:WO2014182631  [Y]
 (BAXTER INT et al.)
Type:Patent literature
Publication No.:WO2022192636  [XP]
 (LILLY CO ELI et al.)
Type:Patent literature
Publication No.:WO2022192639  [XP]
 (LILLY CO ELI et al.)
Type:Patent literature
Publication No.:WO2022150735  [XP]
 (LILLY CO ELI et al.)
Type:Patent literature
Publication No.:WO2023076995  [E]
 (LILLY CO ELI et al.)
Type:Non-patent literature
Publication information:[X]   MINTUN MARK A. ET AL: "Donanemab in Early Alzheimer's Disease", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 384, no. 18, 6 May 2021 (2021-05-06), pages 1691 - 1704, XP055910565, ISSN: 0028-4793, DOI: 10.1056/NEJMoa2100708
DOI: http://dx.doi.org/10.1056/NEJMoa2100708
Type:Non-patent literature
Publication information:[X]   SHCHERBININ SERGEY ET AL: "OC15 - Flortaucipir in the trailblazer-ALZ trial", JOURNAL OF PREVENTION OF ALZHEIMER'S DISEASE, vol. 8, no. Suppl.1, 9 November 2021 (2021-11-09), pages S22 - S23, XP093058240, ISSN: 2426-0266, DOI: 10.14283/jpad.2021.57
DOI: http://dx.doi.org/10.14283/jpad.2021.57
Type:Non-patent literature
Publication information:[XDY]   PONTECORVO MICHAEL J. ET AL: "Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition", BRAIN, vol. 140, no. Part 3, 11 January 2017 (2017-01-11), pages 748 - 763, XP093057211, ISSN: 0006-8950, DOI: 10.1093/brain/aww334
DOI: http://dx.doi.org/10.1093/brain/aww334
Type:Non-patent literature
Publication information:[XDY]   SOUTHEKAL SUDEEPTI ET AL: "Flortaucipir F18 Quantitation Using Parametric Estimation of Reference Signal Intensity", THE JOURNAL OF NUCLEAR MEDICINE, vol. 59, no. 6, 1 June 2018 (2018-06-01), pages 944 - 951, XP093057203, ISSN: 0161-5505, Retrieved from the Internet DOI: 10.2967/jnumed.117.200006
DOI: http://dx.doi.org/10.2967/jnumed.117.200006
Type:Non-patent literature
Publication information:[XDY]   PONTECORVO MICHAEL J ET AL: "A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia", BRAIN, vol. 142, no. 6, 1 June 2019 (2019-06-01), pages 1723 - 1735, XP093057199, ISSN: 0006-8950, Retrieved from the Internet DOI: 10.1093/brain/awz090
DOI: http://dx.doi.org/10.1093/brain/awz090
Type:Non-patent literature
Publication information:[XY]   SCHWARZ ADAM J: "The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders", NEUROTHERAPEUTICS, vol. 18, no. 2, 1 April 2021 (2021-04-01), pages 686 - 708, XP037557905, ISSN: 1933-7213, [retrieved on 20210412], DOI: 10.1007/S13311-021-01027-4
DOI: http://dx.doi.org/10.1007/s13311-021-01027-4
Type:Non-patent literature
Publication information:[XY]   SIDEROWF ANDREW D ET AL: "COMPARISON OF REGIONAL FLORTAUCIPIR PET TO QUANTITATIVE TAU AND AMYLOID IMMUNOASSAY IN PATIENTS WITH ALZHEIMER'S DISEASE PATHOLOGY: A PILOT CLINICO-PATHOLOGICAL STUDY", ALZHEIMER'S & DEMENTIA, vol. 13, no. 7, 17 July 2017 (2017-07-17), XP085216814, ISSN: 1552-5260, DOI: 10.1016/J.JALZ.2017.06.1038
DOI: http://dx.doi.org/10.1016/j.jalz.2017.06.1038
Type:Non-patent literature
Publication information:[XY]   FLEISHER A S ET AL: "Tau pet imaging as a screening tool for clinical trials of disease modifying therapies", JOURNAL OF PREVENTION OF ALZHEIMER'S DISEASE, vol. 5, no. 1, OC12, 1 October 2018 (2018-10-01), & 11th Conference Clinical Trials Alzheimer's Disease, 24-27 October 2018, Barcelona, ES, pages S17 - S18, XP009545026, ISSN: 2426-0266, DOI: 10.14283/jpad.2018.39
DOI: http://dx.doi.org/10.14283/jpad.2018.39
Type:Non-patent literature
Publication information:[Y]   LOWE S ET AL: "Treatment with donanemab, A B-amyloid plaque-specific antibody, results in rapid and sustained reduction of amyloid measured by F-18 florbetapir imaging in Alzheimer's disease", JOURNAL OF PREVENTION OF ALZHEIMER'S DISEASE, vol. 6, no. Supplement 1, 1 December 2019 (2019-12-01), & 12th Conference Clinical Trials Alzheimer's Disease, 20191204 to 20191207, San Diego, US, 4-7 December 2019, pages S8, XP009544994, ISSN: 2426-0266, [retrieved on 20191208], DOI: 10.14283/JPAD.2019.47
DOI: http://dx.doi.org/10.14283/jpad.2019.47
Type:Non-patent literature
Publication information:[Y]   JEFF SEVIGNY ET AL: "The antibody aducanumab reduces A&bgr; plaques in Alzheimer’s disease", NATURE, vol. 537, no. 7618, 31 August 2016 (2016-08-31), pages 50 - 56, XP055394640, ISSN: 0028-0836, DOI: 10.1038/nature19323
DOI: http://dx.doi.org/10.1038/nature19323
Type:Non-patent literature
Publication information:[Y]   HONIG LAWRENCE S. ET AL: "Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease", THE NEW ENGLAND JOURNAL OF MEDICINE, vol. 378, no. 4, 25 January 2018 (2018-01-25), pages 321 - 330, XP055954469, ISSN: 0028-4793, Retrieved from the Internet DOI: 10.1056/NEJMoa1705971
DOI: http://dx.doi.org/10.1056/NEJMoa1705971
Cited inby applicant
Type:Patent literature
Publication No.:US8679498  
Type:Patent literature
Publication No.:US8961972  
Type:Patent literature
Publication No.:US2017038999  
Type:Patent literature
Publication No.:US10647759  
Type:Patent literature
Publication No.:US11078261  
Type:Patent literature
Publication No.:US7195761  
Type:Patent literature
Publication No.:US2006039906  
Type:Patent literature
Publication No.:US7892545  
Type:Patent literature
Publication No.:US8591894  
Type:Patent literature
Publication No.:US7771722  
Type:Patent literature
Publication No.:US2007190046  
Type:Patent literature
Publication No.:US10081625  
Type:Patent literature
Publication No.:WO2022020663  
Type:Non-patent literature
Publication information:  VILLEMAGNE ET AL., ANN NEUROL, vol. 69, 2011, pages 181 - 192
Type:Non-patent literature
Publication information:  PONTECORVO ET AL.: "A Multicentre Longitudinal Study of Flortaucipir (18F) in Normal Ageing, Mild Cognitive Impairment and Alzheimer's disease Dementia", BRAIN, vol. 142, 2019, pages 1723 - 35
Type:Non-patent literature
Publication information:  DEVOUS ET AL.: "Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F18", JOURNAL OF NUCLEAR MEDICINE, vol. 59, 2018, pages 937 - 43
Type:Non-patent literature
Publication information:  SOUTHEKAL ET AL.: "Flortaucipir F18 Quantitation Using Parametric Estimation of Reference Signal Intensity", J. NUCL. MED., vol. 59, 2018, pages 944 - 951
Type:Non-patent literature
Publication information:  FLEISHER ET AL.: "Positron Emission Tomography Imaging With F18-flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes", JAMA NEUROLOGY, vol. 77, 2020, pages 829 - 39
Type:Non-patent literature
Publication information:  PONTECORVO ET AL.: "Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition", BRAIN, 2017, pages 1 - 16
Type:Non-patent literature
Publication information:  DEVOUS ET AL.: "Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F18", J. NUCL. MED., vol. 59, 2018, pages 937 - 943
Type:Non-patent literature
Publication information:  BAO ET AL., AGING NEUROSCI, vol. 13, 2021, pages 624330
Type:Non-patent literature
Publication information:  TZOURIO-MAZOYER ET AL., NEUROIMAGE, vol. 15, 2002, pages 273 - 289
Type:Non-patent literature
Publication information:  OSSENKOPPELE ET AL., JAMA NEUROLOGY, 2021
Type:Non-patent literature
Publication information:  PONTECORVO ET AL., BRAIN, 2019
Type:Non-patent literature
Publication information:  SOUTHEKAL ET AL., JOURNAL OF NUCLEAR MEDICINE, 2018